02-19906. New Animal Drugs; Change of Sponsor's Name  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Final rule.

    SUMMARY:

    The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor's name from Blue Ridge Pharmaceuticals, Inc., to IDEXX Pharmaceuticals, Inc.

    DATES:

    This rule is effective August 7, 2002.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Lonnie W. Luther, Center for Veterinary Medicine (HFV-101), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-0209, e-mail: lluther@cvm.fda.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Blue Ridge Pharmaceuticals, Inc., 4249-105 Piedmont Pkwy., Greensboro, NC 27410, has informed FDA of a change of name to IDEXX Pharmaceuticals, Inc. Accordingly, the agency is amending the regulations in 21 CFR 510.600(c)(1) and (c)(2) to reflect the change.

    This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

    Start List of Subjects

    List of Subjects in 21 CFR Part 510

    • Administrative practice and procedure
    • Animal drugs
    • Labeling
    • Reporting and recordkeeping requirements
    End List of Subjects Start Amendment Part

    Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is amended as follows:

    End Amendment Part Start Part

    PART 510—NEW ANIMAL DRUGS

    End Part Start Amendment Part

    1. The authority citation for 21 CFR part 510 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

    End Authority Start Amendment Part

    2. Section 510.600 is amended in the table in paragraph (c)(1) by removing the entry for “Blue Ridge Pharmaceuticals, Inc.” and by alphabetically adding an entry for “IDEXX Pharmaceuticals, Inc.”; and in the table in paragraph (c)(2) by revising the entry for “065274” to read as follows.

    End Amendment Part
    Names, addresses, and drug labeler codes of sponsors of approved applications.
    * * * * *

    (c) * * *

    (1) * * *

    Firm name and addressDrug labeler code
    *          *          *          *          *          *          *
    IDEXX Pharmaceuticals, Inc., 4249-105 Piedmont Pkwy., Greensboro, NC 27410065274
    *          *          *          *          *          *          *

    (2) * * *

    Drug labeler codeFirm name and address
    *          *          *          *          *          *          *
    065274IDEXX Pharmaceuticals, Inc., 4249-105 Piedmont Pkwy., Greensboro, NC 27410
    *          *          *          *          *          *          *
    Start Signature

    Dated: July 19, 2002.

    Andrew J. Beaulieu,

    Acting Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.

    End Signature End Supplemental Information

    [FR Doc. 02-19906 Filed 8-6-02; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Effective Date:
8/7/2002
Published:
08/07/2002
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
02-19906
Dates:
This rule is effective August 7, 2002.
Pages:
51079-51079 (1 pages)
PDF File:
02-19906.pdf
CFR: (1)
21 CFR 510.600